Announcements Trials
Browse Landscape

Phase

Phase 2 4Phase NA 1Phase EARLY_PHASE1 1Phase 3 1Phase 2/3 1Phase 1 1

Status

Completed 687Unknown 267Recruiting 192Terminated 146Active not recruiting 94Not yet recruiting 73Withdrawn 48Enrolling by invitation 4Suspended 3

Sponsor Class

OTHER 4

Study Type

Interventional 4

Sponsor

Cancer Type

Gastrointestinal 3Gynecologic 1

Conditions

Uterine Cervical Neoplasms 1Gastric Cancer Peritoneal Metastases 1Esophageal Squamous Cell Carcinoma 1Clinical Stage I Gastric Cancer AJCC v8 1

Interventions

Cisplatin 4130-nm albumin-bound paclitaxel 3camrelizumab 2Oxaliplatin 2Nivolumab 2Magnetic Resonance Spectroscopy 2Laparoscopy 2Bevacizumab 2trilaciclib 1trastuzumab deruxtecan 1toripalimab 1selinexor 1sacituzumab govitecan 1ribociclib 1olaparib 1nimotuzumab 1lenvatinib 1fluorodopa F 18 1durvalumab 1decitabine and cedazuridine drug combination 1dalpiciclib 1cemiplimab 1carfilzomib 1apatinib 1anlotinib 1abemaciclib 1Valacyclovir 1Temozolomide 1Taxes 1Surgical Procedures, Operative 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Phase 2 × Enrolling by invitation × Cisplatin × Clear all
NCT07517419 2026-04-08

PIPAC in Gastric Peritoneal Metastasis

Chinese University of Hong Kong

Phase 2 Enrolling by invitation
30 enrolled
Gastrointestinal

Gastric Cancer Peritoneal Metastases

NCT07139951 2025-12-31

HORIZON

Mayo Clinic

Phase 2 Enrolling by invitation
16 enrolled
Gastrointestinal

Clinical Stage I Gastric Cancer AJCC v8

NCT07312578 2025-12-31

Nimotuzumab,Camrelizumab, and Neoadjuvant Chemotherapy(nCT) in the Treatment of Esophageal Squamous Cell Carcinoma

Peking University

Phase 2 Enrolling by invitation
48 enrolled
Gastrointestinal

Esophageal Squamous Cell Carcinoma

NCT06786780 2025-03-26

ECCO

Chongqing University Cancer Hospital

Phase 2 Enrolling by invitation
50 enrolled
Gynecologic

Uterine Cervical Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡